Overview
Larisa Mendeleeva practices in Moscow, Russian Federation. Ms. Mendeleeva is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Plasmacytoma, Multiple Myeloma, Primary Amyloidosis, Leukemia, and Bone Marrow Transplant.
Her clinical research consists of co-authoring 38 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Plasmacytoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- PlasmacytomaMs. Mendeleeva isElite. Learn about Plasmacytoma.
- Distinguished
- Multiple MyelomaMs. Mendeleeva isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Bone Marrow TransplantMs. Mendeleeva isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Ms. Mendeleeva isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult T-Cell LeukemiaMs. Mendeleeva isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisMs. Mendeleeva isExperienced. Learn about Agranulocytosis.
- LeukemiaMs. Mendeleeva isExperienced. Learn about Leukemia.
- Neurotoxicity SyndromesMs. Mendeleeva isExperienced. Learn about Neurotoxicity Syndromes.
- POEMS SyndromeMs. Mendeleeva isExperienced. Learn about POEMS Syndrome.